August 28, 2025

FDA Requests Confirmatory Evidence on Wet AMD Therapy

Outlook Therapeutics’ drug for wet age-related macular degeneration faces an FDA approval setback.

Conexiant

August 21, 2025

FDA Grants RMAT to VeonGen Gene Therapy

VG801 is being developed for Stargardt disease and other ABCA4-related retinal disorders.

Retinal Physician

August 20, 2025

One Hour on Phone, Fewer Blinks

Blinking decreases and eye strain increases during one hour of smartphone use, with dynamic screen changes from social media reels creating the highest visual load.

Conexiant

August 12, 2025

Ocular Therapeutix Announces FDA Approves NPDR Trial Plan for OTX-TKI

A Special Protocol Assessment (SPA) establishes a regulatory path for Ocular Therapeutix’s Axpaxli in diabetic eye disease.

Ophthalmology Management

August 11, 2025

First MacTel Patient Receives Encelto Treatment

The procedure marks the initial commercial use since FDA approval of the cell therapy earlier this year.

Retinal Physician

August 05, 2025

Large US Study Adds to Connection Between NAION Risks and GLP-1 Drugs

Semaglutide and liraglutide showed the highest risk, while dulaglutide and exenatide were not significantly associated with NAION.

Ophthalmology Management

August 05, 2025

What Do Patients Look for in Health Care Facilities?

An analysis of online reviews of health care facilities identified language patterns associated with positive or negative patient experiences.

Conexiant

August 01, 2025

ILM Peel for Macular Hole

Expert vitreoretinal surgeons explain their techniques and strategies in Retinal Physician's new Surgical Pearls video series.

Retinal Physician

June 01, 2025

Preservation of Vision in GA in ARCHER Trial Continues Evaluation in ARCHER II

Discover the potential breakthrough in preserving vision in geographic atrophy presented by Dr. Priya Vakharia at the Retina World Congress.

Retinal Physician